ArticleInternational journal of telemedicine and applications2026
Integrating Large Language Models Into UAE Community Pharmacies: Pharmacists' Perspectives on Benefits, Concerns, and Implementation Barriers.
Article in International journal of telemedicine and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating Large Language Models Into UAE Community Pharmacies: Pharmacists' Perspectives on Benefits, Concerns, and Implementation Barriers.International journal of telemedicine and applications · 2026Article
- Digital twins in precision pharmacotherapy: emerging applications, challenges, and future directions.Frontiers in digital health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The UAE's rapid economic growth and adoption of advanced healthcare technologies necessitate understanding pharmacists' perspectives on large language models (LLMs) to address implementation challenges and align with the nation's digital health initiatives. Aim: This study explored UAE pharmacists' perceived benefits, concerns, and barriers to LLM adoption, as well as factors contributing to heightened concerns in community pharmacies. Methods: A survey-based cross-sectional study was conducted among 528 community pharmacists (51.3% female) in the UAE between October and November 2024. Pharmacists completed a validated questionnaire assessing socio-demographic information, perceived benefits, concerns, and barriers related to LLM use. Binary logistic regression was applied to identify factors associated with concerns about LLMs. Results: The least-perceived benefits of LLMs included providing around-the-clock support (37.3%), designing personalized care plans (74.4%), and improving patient outcomes (77.0%). Barriers included the need for human supervision (54.7%), insufficient training (32.4%), lack of pharmacy-focused LLM programs (28.4%), and inadequate resources (28.4%). Key concerns were technical failures or downtime (97.5%), hacking vulnerabilities (97.2%) and limited capacity for empathy, cultural understanding, or ethical considerations in healthcare (95.6%). Increased age was significantly associated with greater concerns (OR = 1.124, p < 0.001). Conversely, pharmacists with master's or doctoral degrees (OR = 0.483, p = 0.008) and those likely to use LLMs in the future (OR = 0.357, Conclusion: The integration of LLMs into community pharmacy practice faces challenges, including hacking risks, security vulnerabilities, insufficient empathy, and technical failures. Targeted interventions such as enhanced training, robust security measures, and tailored LLM solutions are essential to address these barriers and support safe adoption in pharmacy settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.